Phialogics AG
Immune modulating therapeutics
Our R&D platform is focused on developing immune modulating therapeutics for patients with autoimmune diseases
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
06.10.2023
Four startups to accelerate their therapeutics with BaseLaunch (startupticker.ch)
19.04.2023
Phialogics closes 600,000 € pre-seed financing round (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Phialogics AG
Immune modulating therapeutics
Website:
www.phialogics.com/
Headquarter:
Allschwil
Foundation Date:
December 2022
Technology:
- Biotech